1. Biomarker tests for the diagnosis of Alzheimer's disease: Generating evidence to inform insurance coverage determinations. Issue 6 (7th October 2013) Authors: Pearson, Steven D.; Ollendorf, Daniel A.; Colby, Jennifer A. Journal: Alzheimer's & dementia Issue: Volume 9:Issue 6(2013) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease. (1st March 2022) Authors: Whittington, Melanie D.; Campbell, Jonathan D.; Rind, David; Fluetsch, Noemi; Lin, Grace A.; Pearson, Steven D. Journal: Neurology Issue: Volume 98:Number 9(2022) Page Start: e968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease. (1st March 2022) Authors: Whittington, Melanie D.; Campbell, Jonathan D.; Rind, David; Fluetsch, Noemi; Lin, Grace A.; Pearson, Steven D. Journal: Neurology Issue: Volume 98:Number 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evolving targets for sedation during mechanical ventilation. Issue 1 (February 2020) Authors: Pearson, Steven D.; Patel, Bhakti K. Journal: Current opinion in critical care Issue: Volume 26:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Management of Respiratory Failure: Ventilator Management 101 and Noninvasive Ventilation. Issue 4 (April 2022) Authors: Pearson, Steven D.; Koyner, Jay L.; Patel, Bhakti K. Journal: Clinical journal of the American Society of Nephrology Issue: Volume 17:Issue 4(2022) Page Start: 572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of Aducanumab. (1st March 2022) Authors: Campbell, Jonathan D.; Whittington, Melanie D.; Pearson, Steven D. Journal: Neurology Issue: Volume 98:Number 9(2022) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of Aducanumab. (1st March 2022) Authors: Campbell, Jonathan D.; Whittington, Melanie D.; Pearson, Steven D. Journal: Neurology Issue: Volume 98:Number 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tackling the hepatitis C cost problem: A test case for tomorrow's cures. Issue 5 (22nd September 2015) Authors: Simon, Rachel E.; Pearson, Steven D.; Hur, Chin; Chung, Raymond T. Journal: Hepatology Issue: Volume 62:Issue 5(2015:Nov.) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States. Issue 3 (March 2022) Authors: Mandrik, Olena; Fotheringham, James; Ren, Shijie; Tice, Jeffrey A.; Chapman, Richard H.; Stevenson, Matthew D.; Pearson, Steven D.; Herron-Smith, Serina; Agboola, Foluso; Thokala, Praveen Journal: Clinical journal of the American Society of Nephrology Issue: Volume 17:Issue 3(2022) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Why the Coming Debate Over the QALY and Disability Will be Different. Issue 2 (2019) Authors: Pearson, Steven D. Editors: Coleman, Carl H. Journal: Journal of law, medicine & ethics Issue: Volume 47:Issue 2(2019) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗